1. Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women. Issue 4 (21st September 2021) Authors: Pene Dumitrescu, Teodora; Greene, Thomas J.; Joshi, Samit R.; Xu, Jianfeng; Johnson, Mark; Halliday, Fiona; Butcher, Laurie; Zimmerman, Eric; Webster, Lindsey; Pham, Theresa T.; Lataillade, Max; Min, Sherene Other Names: Bies Rob guestEditor.; Wright Dan guestEditor. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 4(2022) Page Start: 1704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I evaluation of pharmacokinetics and tolerability of the HIV‐1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults. Issue 9 (4th March 2021) Authors: Pene Dumitrescu, Teodora; Joshi, Samit R.; Xu, Jianfeng; Greene, Thomas J.; Johnson, Mark; Butcher, Laurie; Zimmerman, Eric; Webster, Lindsey; Pham, Theresa T.; Lataillade, Max; Min, Sherene Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 9(2021) Page Start: 3501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗